AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 387497
Drug: Hydrocortisone alcoholic
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Hydrocortisone alcoholic solution
Trial: 31028547
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 3D and NBI
Trial: 31443072
Drug: Unfavorable outcome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unfavorable outcome after aSAH treatment
Trial: 28338977
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg d-cycloserine (DCS)
Trial: 26278911
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human erythropoietin (rEPO), high-dose, repetitive administration
Trial: 24123224
Drug: Isradipine 5
RxNorm normalized name: isradipine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine 5 mg CR
Trial: 24123224
Drug: Isradipine 10
RxNorm normalized name: isradipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine 10 mg CR
Trial: 24123224
Drug: Isradipine 20
RxNorm normalized name: Isradipine
DrugBank: Isradipine (DB00270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isradipine 20 mg CR
Trial: 24123224
Drug: Isradipine 10
RxNorm normalized name: isradipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine 10 mg daily
Trial: 8732377
Drug: Streptokinase with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Streptokinase with subcutaneous heparin
Trial: 8732377
Drug: Streptokinase with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Streptokinase with intravenous heparin
Trial: 1564212
Drug: Accelerated recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Accelerated recombinant tissue-type plasminogen activator (rt-PA) with intravenous heparin
Trial: 1564212
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of streptokinase, rt-PA and intravenous heparin
Trial: 2898025
Drug: Conventional injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional injection treatment
Trial: 31204383
Drug: Multiple small
RxNorm normalized name: smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Solution [ACAM2000]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple small incisions and negative-pressure wound therapy (NPWT)
Trial: 31204383
Drug: Traditional comprehensive
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional comprehensive treatment with additional small incisions and NPWT
Trial: 31204383
Drug: Traditional comprehensive
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional comprehensive treatment
Trial: 30522663
Drug: Low-dose drug-coated
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose drug-coated balloon (DCB)
Trial: 24658598
Drug: Oral double-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral double-dose esomeprazole 40 mg twice daily (n=93)
Trial: 24658598
Drug: Oral standard-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral standard-dose esomeprazole 40 mg once daily (n=94)
Trial: 19766977
Drug: Osteopathic manipulative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Osteopathic manipulative treatment with usual obstetric care
Trial: 19766977
Drug: Usual obstetric
RxNorm normalized name: chlorhexidine gluconate Topical Cream [Hibitane Obstetric]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual obstetric care and sham ultrasound treatment
Trial: 16260511
Drug: Ultralow-dose transdermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultralow-dose transdermal estradiol (0.014 mg/d)
Trial: 11876692
Drug: rhIL‐11 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhIL‐11 15 microg/kg once weekly
Trial: 11876692
Drug: rhIL‐11 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhIL‐11 7.5 microg/kg twice weekly
Trial: 1670631
Drug: 3.0 g
RxNorm normalized name: LACTIC ACID 23.0 g in 1 L TOPICAL SOLUTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.0 g oral sulfasalazine plus 20 mg twice daily rectal prednisolone enemas (group I, N = 18)
Trial: 1670631
Drug: 2.0 g
RxNorm normalized name: Fifty50 2.0 Glucose Meter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0 g twice daily rectal sucralfate enemas plus oral placebo (group II, N = 19)
Trial: 6623019
Drug: Nonsteroid anti-inflammatory
RxNorm normalized name: Surpass Anti-Inflammatory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonsteroid anti-inflammatory drugs (NSAIDs)
Trial: 6623019
Drug: Remission-inducing drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remission-inducing drugs (RIDs)
Trial: 28235887
Drug: Capsaicin administration
RxNorm normalized name: Capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Capsaicin administration to evoke coughs
Trial: 28235887
Drug: Methacholine administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methacholine administration to induce bronchoconstriction
Trial: 26965791
Drug: Prednisolone 35
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone 35 mg qd
Trial: 12817520
Drug: Etoricoxib 120
RxNorm normalized name: etoricoxib 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etoricoxib 120 mg qd
Trial: 9106374
Drug: Overall treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall treatment response
Trial: 15701470
Drug: Optimal pacing
RxNorm normalized name: Optima Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimal pacing therapy
Trial: 1535578
Drug: Clarithromycin 250
RxNorm normalized name: clarithromycin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin 250 mg b.i.d.
Trial: 7499006
Drug: Clarithromycin 500
RxNorm normalized name: clarithromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin 500 mg q.d.
Trial: 7499006
Drug: 14-hydroxy metabolite
RxNorm normalized name: 4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one
DrugBank: Oxycodone (DB00497)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 14-hydroxy metabolite with 500 mg q.d.
Trial: 7499006
Drug: 14-hydroxy metabolite
RxNorm normalized name: 4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one
DrugBank: Oxycodone (DB00497)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 14-hydroxy metabolite with 250 mg b.i.d.
Trial: 31993753
Drug: Oral cryotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cryotherapy (OC) - cooling the mouth with ice for ≥ 30 minutes during chemotherapy infusions.
Trial: 31993753
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no oral cryotherapy).
Trial: 31993753
Drug: Oral cryotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cryotherapy (OC).
Trial: 27208923
Drug: SFO +
RxNorm normalized name: Sulfonylurea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SFO + LEU (4.2 g of leucine)
Trial: 27208923
Drug: SFO +
RxNorm normalized name: Sulfonylurea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SFO + ALA (4.2 g of alanine)
Trial: 25280603
Drug: Kyrobak (Radiancy,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kyrobak (Radiancy, Hod-hasharon, Israel) self-treatment for 10 minutes, one to three times per day, for 3 weeks
Trial: 25280603
Drug: Kyrobak (Radiancy,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kyrobak (Radiancy, Hod-hasharon, Israel) self-treatment
Trial: 23528101
Drug: rFVIII-FS prophylaxis
RxNorm normalized name: Derma-Smoothe FS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rFVIII-FS prophylaxis (25 IU kg(‐1), three times weekly)
Trial: 21900595
Drug: Alcohol intake
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol intake levels of 3.4 g/d or less
Trial: 21900595
Drug: Alcohol intake
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol intake levels of more than 3.4 g/d
Trial: 21900595
Drug: Alcohol intake
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol intake levels of 30 g/d or less
Trial: 21900595
Drug: Alcohol intake
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol intake levels of more than 30 g/d
Trial: 19143021
Drug: Fractional radiofrequency
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fractional radiofrequency (FRF) treatment using Renesis device, delivering RF energy at 72 degrees C for 4 seconds.
Trial: 15231555
Drug: Computerised cognitive-behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computerised cognitive-behavioural therapy (CBT)
Trial: 370042
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg of supplementary vitamin C daily
Trial: 30382496
Drug: Sequential practice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential practice schedule
Trial: 23494898
Drug: Guided Disclosure
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guided Disclosure Protocol (GDP) - writing about the patient's diagnosis and treatment for 15 minutes a day over 3 days
Trial: 22180357
Drug: Enalapril (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (20 mg/d, n = 47)
Trial: 22180357
Drug: Perindopril (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril (4 mg/d, n = 45)
Trial: 19691482
Drug: Tirofiban (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tirofiban (50 ng mL(‐1))
Trial: 19691482
Drug: PSI-697 (low-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PSI-697 (low-dose 2 m)
Trial: 19691482
Drug: PSI-697 (high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PSI-697 (high-dose 20 m)
Trial: 11468942
Drug: Mizolastine pediatric
RxNorm normalized name: mizolastine
DrugBank: Mizolastine (DB12523)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mizolastine pediatric solution (0.15 mg/kg once daily)
Trial: 11468942
Drug: Mizolastine pediatric
RxNorm normalized name: mizolastine
DrugBank: Mizolastine (DB12523)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mizolastine pediatric solution
Trial: 30247714
Drug: Protein supplementation
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein supplementation (21 g protein, 3 g total leucine, 9 g carbohydrate, 3 g fat; n = 21)
Trial: 30247714
Drug: Placebo (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (0 g protein, 25 g carbohydrate, 6 g fat; n = 20)
Trial: 28643799
Drug: Aflibercept treatment
RxNorm normalized name: Aflibercept
DrugBank: Aflibercept (DB08885)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Aflibercept treatment initiated for nAMD
Trial: 26632710
Drug: Quadruple therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadruple therapy based on E‐test results (rabeprazole + bismuth potassium citrate + amoxicillin + clarithromycin) for 14 days
Trial: 26632710
Drug: Empirical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empirical therapy (rabeprazole + bismuth potassium citrate + amoxicillin + clarithromycin)
Trial: 25098068
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose antibiotic before inguinal hernia mesh repair
Trial: 14687438
Drug: rosuvastatin 10-40
RxNorm normalized name: rosuvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosuvastatin 10-40 mg
Trial: 14687438
Drug: atorvastatin 10-80
RxNorm normalized name: amlodipine
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: atorvastatin 10-80 mg
Trial: 14687438
Drug: simvastatin 10-80
RxNorm normalized name: ezetimibe
DrugBank: Ezetimibe (DB00973)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: simvastatin 10-80 mg
Trial: 14687438
Drug: pravastatin 10-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pravastatin 10-40 mg
Trial: 9042739
Drug: Verbal-visual combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verbal-visual combination
Trial: 20124953
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil with MPA-AUC less than 30 mg hr/L
Trial: 20124953
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil with MPA-AUC more than or equal to 30 mg hr/L
Trial: 20124953
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil with MPA-AUC less than 30 mg hr/L in tacrolimus-treated patients
Trial: 20124953
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil with MPA-AUC more than or equal to 30 mg hr/L in tacrolimus-treated patients
Trial: 16796276
Drug: 70 mg
RxNorm normalized name: silybin 70 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 70 mg alendronate once weekly
Trial: 1360032
Drug: Routine doppler
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine doppler ultrasound examinations of the umbilical and uterine arteries during pregnancy (first at 19-22 weeks, then monthly for high risk or once at 32 weeks for low risk)
Trial: 28235424
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (Bobath therapy)
Trial: 30641621
Drug: Chinese medicine
RxNorm normalized name: BUTYLENE GLYCOL 48 g in 240 mL CUTANEOUS TAPE [QIZHOUGUAI Chinese medicine patch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese medicine group (CM) - Astragalus Granule (AG)
Trial: 30641621
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine group (WM) - Basic treatment with aerosol inhalation (Budesonide suspension and Terbutaline Sulphate Solution)
Trial: 23723319
Drug: Bivalent HPV
RxNorm normalized name: HPV, bivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bivalent HPV vaccine (HPV16/18), administered at 0, 1, and 6 months
Trial: 23723319
Drug: Bivalent HPV
RxNorm normalized name: HPV, bivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bivalent HPV vaccine (HPV16/18)
Trial: 22019331
Drug: Calcitriol (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcitriol (0.5 μg, 2 doses per week for 48 weeks)
Trial: 19436116
Drug: pilsicainide (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pilsicainide (150 mg/day)
Trial: 19436116
Drug: bepridil (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bepridil (200 mg/day)
Trial: 17263861
Drug: Rectal Voltarol
RxNorm normalized name: totarol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal Voltarol
Trial: 12905468
Drug: Infliximab (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infliximab (3 mg/kg)
Trial: 11529382
Drug: Ceftibuten (9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftibuten (9 mg/kg/day) for 10 days after initial ceftriaxone (75 mg/kg/day)
Trial: 11529382
Drug: Ceftriaxone (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone (75 mg/kg/day)
Trial: 11529382
Drug: Ceftibuten (9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftibuten (9 mg/kg/day)
Trial: 8142127
Drug: 10% sucralfate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% sucralfate suspension (Group 2)
Trial: 8142127
Drug: Antacid containing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antacid containing sodium alginate (Group 1)
Trial: 3203571
Drug: 30 g
RxNorm normalized name: Lancet Unilet 30 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 g of fructose
Trial: 27620342
Drug: EXER +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EXER + CBT (exercise program plus cognitive-behavioral therapy)
Trial: 27620342
Drug: CONTROL (routine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CONTROL (routine treatment)
Trial: 25780837
Drug: Rural patients
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rural patients receiving surgical treatment for hip osteoarthritis
Trial: 25780837
Drug: Urban patients
RxNorm normalized name: Geum urbanum root extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urban patients receiving surgical treatment for hip osteoarthritis
Trial: 24326918
Drug: Rubric exam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rubric exam preparation group
Trial: 24326918
Drug: Nonrubric exam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonrubric exam preparation group
Trial: 21353262
Drug: Moderate alcohol
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Moderate alcohol consumption (beer, ∼26 g alcohol)
Trial: 19767761
Drug: 16 G-needle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16 G-needle
Trial: 19767761
Drug: 18 G-needle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 18 G-needle
Trial: 9118185
Drug: F dentifrice
RxNorm normalized name: Stomodine F
FDA approved: no
EMA approved: no
PMDA approved: no
Description: F dentifrice + F lozenges (0.25 mg F x 6/day)
Trial: 9118185
Drug: F dentifrice
RxNorm normalized name: Stomodine F
FDA approved: no
EMA approved: no
PMDA approved: no
Description: F dentifrice + F chewing-gum (0.25 mg F x 6/day)
Trial: 3538481
Drug: Oral nifedipine
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral nifedipine (20 mg thrice daily)
Trial: 25881320
Drug: Bravecto™ (fluralaner),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bravecto™ (fluralaner), 25 mg/kg body weight, single oral administration
Trial: 25881320
Drug: Advocate® (imidacloprid/moxidectin),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Advocate® (imidacloprid/moxidectin), 10 mg imidacloprid/kg body weight and 2.5 mg moxidectin/kg body weight, topical administration on three occasions at 28-day intervals
Trial: 23741066
Drug: Quisinostat (JNJ-26481585)
RxNorm normalized name: Quisinostat
DrugBank: Quisinostat (DB12985)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quisinostat (JNJ-26481585) administered orally, once daily in three weekly cycles, with doses ranging from 2-12 mg for continuous dosing and 6-19 mg for intermittent dosing schedules.
Trial: 23741066
Drug: Intermittent dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent dosing schedules (four days on/three days off; every Monday, Wednesday, Friday; every Monday and Thursday)
Trial: 25503082
Drug: Tapentadol ER
RxNorm normalized name: tapentadol Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tapentadol ER (100-250 mg bid)
Trial: 21162697
Drug: Open-label titration
RxNorm normalized name: BOTTLE OPENER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open-label titration phase (Tapentadol ER)
Trial: 18971855
Drug: Topical 0.05%
RxNorm normalized name: ingenol topical 0.05% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 0.05% ciclosporin A (CsA) for 3 months after surgery
Trial: 18971855
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard topical therapy)
Trial: 12941721
Drug: Dalteparin (5000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalteparin (5000 units subcutaneous injection once daily)
Trial: 12941721
Drug: Placebo (physiological
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (physiological saline equivalent volume once daily)
Trial: 11019420
Drug: Trimetazidine (TMS)
RxNorm normalized name: trimetazidine
DrugBank: Trimetazidine (DB09069)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimetazidine (TMS) 60 mg
Trial: 11019420
Drug: Trimetazidine (TMS)
RxNorm normalized name: trimetazidine
DrugBank: Trimetazidine (DB09069)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimetazidine (TMS) added to selected antianginal drugs
Trial: 8618579
Drug: Aerosolized synthetic
RxNorm normalized name: Synthetic camphor
DrugBank: Synthetic camphor (DB14156)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosolized synthetic surfactant (13.5 mg of dipalmitoylphosphatidylcholine per milliliter) administered continuously for up to five days
Trial: 8618579
Drug: Placebo (0.45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (0.45 percent saline) administered continuously for up to five days
Trial: 1570391
Drug: No patches
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No patches
Trial: 2802118
Drug: Diazepam (0.28
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (0.28 mg/kg)
Trial: 26749219
Drug: HYD 30
RxNorm normalized name: sod/pot/Cl/cit/Zn/mag/carbohyd 305 mg-175 mg-70 mg-2.5 gram-2 mg-40 mg-9 gram ORAL POWDER IN PACKET (EA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HYD 30 mg once daily